Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · IEX Real-Time Price · USD
1.76
-0.01 (-0.56%)
Mar 17, 2023, 4:00 PM EDT - Market closed
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 - 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.39 | 0.36 | 0.37 | 0.24 | 0.38 | 0.51 | 0.38 | 0.31 | 0.28 | 0.26 | |
| Revenue Growth (YoY) | 7.52% | -1.91% | 49.61% | -35.34% | -25.14% | 32.63% | 21.82% | 11.65% | 8.07% | -42.44% | |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0.6 | 1.81 | 1.73 | 0.63 | 0.02 | 0 | |
| Gross Profit | 0.39 | 0.36 | 0.37 | 0.24 | -0.22 | -1.31 | -1.35 | -0.32 | 0.26 | 0.26 | |
| Selling, General & Admin | 13.18 | 11.84 | 8.22 | 5.76 | 8.01 | 14.23 | 23 | 14.36 | 8.54 | 7 | |
| Research & Development | 27.11 | 17.38 | 11.24 | 11.16 | 8.16 | 7.88 | 15.01 | 10.59 | 6.66 | 3.95 | |
| Other Operating Expenses | 0 | 0 | 0 | -0 | 0.9 | 2.17 | 0.79 | 0 | 0 | 0 | |
| Operating Expenses | 40.29 | 29.21 | 19.45 | 16.92 | 17.07 | 24.29 | 38.8 | 24.96 | 15.21 | 10.95 | |
| Operating Income | -39.9 | -28.86 | -19.09 | -16.68 | -17.29 | -25.6 | -40.15 | -25.27 | -14.95 | -10.69 | |
| Interest Expense / Income | 0 | 0 | 0 | 0 | 0.03 | 1.03 | 1.67 | 1.47 | 0.83 | 0.02 | |
| Other Expense / Income | -1.2 | -0.56 | 0.22 | -0.26 | -0.85 | -1.72 | -2.62 | 0.73 | -1.45 | 1.1 | |
| Pretax Income | -38.7 | -28.29 | -19.31 | -16.41 | -16.46 | -24.91 | -39.2 | -27.47 | -14.33 | -11.81 | |
| Net Income | -38.7 | -28.29 | -19.31 | -16.41 | -16.46 | -24.91 | -39.2 | -27.47 | -14.33 | -11.81 | |
| Preferred Dividends | 0.02 | 0.02 | 3.29 | 0.29 | 2.79 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | |
| Net Income Common | -38.73 | -28.32 | -22.6 | -16.71 | -19.25 | -24.93 | -39.23 | -27.5 | -14.35 | -11.84 | |
| Shares Outstanding (Basic) | 44 | 39 | 21 | 6 | 2 | 0 | 0 | 0 | 0 | 0 | |
| Shares Outstanding (Diluted) | 44 | 39 | 21 | 6 | 2 | 0 | 0 | 0 | 0 | 0 | |
| Shares Change | 11.71% | 86.97% | 249.44% | 156.37% | 383.77% | 14.53% | 14.48% | 38.70% | 12.33% | 29.94% | |
| EPS (Basic) | -0.89 | -0.73 | -1.08 | -2.80 | -8.26 | -51.76 | -93.60 | -75.60 | -54.72 | -50.40 | |
| EPS (Diluted) | -0.89 | -0.73 | -1.08 | -2.80 | -8.26 | -51.76 | -93.30 | -87.12 | -63.36 | -50.40 | |
| Free Cash Flow Per Share | -0.80 | -0.60 | -0.79 | -2.23 | -5.66 | -48.54 | -76.03 | -66.92 | -49.62 | -33.78 | |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | -57.92% | -258.41% | -354.12% | -101.14% | 94.49% | 100.00% | |
| Operating Margin | -10337.31% | -8037.60% | -5214.75% | -6816.98% | -4570.21% | -5064.42% | -10534.91% | -8079.50% | -5334.17% | -4123.71% | |
| Profit Margin | -10033.16% | -7887.19% | -6174.32% | -6829.31% | -5089.53% | -4932.88% | -10294.11% | -8789.73% | -5121.21% | -4567.39% | |
| Free Cash Flow Margin | -9022.28% | -6474.93% | -4515.30% | -5451.09% | -3482.77% | -4626.13% | -8361.50% | -7785.02% | -4649.61% | -3072.96% | |
| EBITDA | -38.47 | -27.84 | -18.84 | -15.92 | -15.58 | -22.63 | -36.46 | -25.62 | -13.26 | -11.66 | |
| EBITDA Margin | -9965.80% | -7754.87% | -5147.27% | -6507.70% | -4117.17% | -4476.66% | -9567.70% | -8191.55% | -4732.58% | -4498.98% | |
| Depreciation & Amortization | 0.24 | 0.45 | 0.47 | 0.49 | 0.86 | 1.25 | 1.07 | 0.38 | 0.23 | 0.13 | |
| EBIT | -38.7 | -28.29 | -19.31 | -16.41 | -16.44 | -23.87 | -37.53 | -26 | -13.49 | -11.79 | |
| EBIT Margin | -10026.94% | -7880.50% | -5274.59% | -6709.74% | -4344.35% | -4723.51% | -9848.37% | -8312.62% | -4816.39% | -4549.32% |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).